Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and Harvest Health & Recreation (OTCMKTS:HRVSF – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations.
Valuation and Earnings
This table compares Amphastar Pharmaceuticals and Harvest Health & Recreation”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Amphastar Pharmaceuticals | $719.89 million | 1.36 | $98.09 million | $1.69 | 13.59 |
| Harvest Health & Recreation | N/A | N/A | N/A | N/A | N/A |
Profitability
This table compares Amphastar Pharmaceuticals and Harvest Health & Recreation’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Amphastar Pharmaceuticals | 10.76% | 14.98% | 6.96% |
| Harvest Health & Recreation | N/A | N/A | N/A |
Analyst Ratings
This is a summary of current ratings for Amphastar Pharmaceuticals and Harvest Health & Recreation, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Amphastar Pharmaceuticals | 2 | 6 | 0 | 0 | 1.75 |
| Harvest Health & Recreation | 0 | 0 | 0 | 0 | 0.00 |
Amphastar Pharmaceuticals currently has a consensus price target of $22.50, indicating a potential downside of 2.00%. Given Amphastar Pharmaceuticals’ stronger consensus rating and higher probable upside, research analysts plainly believe Amphastar Pharmaceuticals is more favorable than Harvest Health & Recreation.
Insider and Institutional Ownership
65.1% of Amphastar Pharmaceuticals shares are held by institutional investors. 29.6% of Amphastar Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Amphastar Pharmaceuticals beats Harvest Health & Recreation on 8 of the 8 factors compared between the two stocks.
About Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
About Harvest Health & Recreation
Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.
Receive News & Ratings for Amphastar Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amphastar Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
